tranzyme.com

Tranzyme Pharma


Tranzyme Pharma is a biopharmaceutical company focused on the discovery, development, and commercialization of mechanism-based therapies. The company currently has programs for gastrointestinal motility disorders and retains worldwide rights for these programs. The company’s product portfolio includes, TZP-101, for the treatment of post-operative ileus and severe gastroparesis; and TZP-301, for the treatment of obesity and metabolic syndrome. Tranzyme Pharma is based in North Carolina, United States.
View Top Employees for Tranzyme Pharma
img Website tranzyme.com
img Industry Biotechnology
img Location Canada
img Employees 10
img HQ 4819 Emperor Blvd Ste 400
img Funding 20,000,000 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Website tranzyme.com
img Industry Biotechnology
img Location Canada
img Employees 10
img LinkedIn linkedin.com/company/tranzyme-pharma
img HQ 4819 Emperor Blvd Ste 400
img Funding 20,000,000 USD

Top Tranzyme Pharma Employees